Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-11

Clinical Trial Update: Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating efficacy and safety of Entelon Tab.150mg in patients with chronic venous disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entelon Tab.150mg

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Chronic Venous Disease | Phase 4 | Status: UNKNOWN